A detailed history of Cwm, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cwm, LLC holds 94 shares of BMEA stock, worth $350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94
Previous 19 394.74%
Holding current value
$350
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$4.23 - $10.1 $317 - $757
75 Added 394.74%
94 $1,000
Q2 2024

Jul 09, 2024

BUY
$4.14 - $15.3 $78 - $290
19 New
19 $0

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $109M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.